Zhiyan Du

Title: Zhiyan Du: Innovator in Antibody-Drug Conjugates

Introduction

Zhiyan Du is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work focuses on innovative methods and applications that enhance the effectiveness of cancer treatments.

Latest Patents

Zhiyan Du's latest patents include groundbreaking inventions such as an AXL-targeting antibody and an antibody-drug conjugate. The first patent discloses a new AXL-targeting monoclonal antibody that can effectively bind to purified human AXL protein and multiple AXL proteins on tumor cell surfaces. This antibody demonstrates high effectiveness and specificity, along with low immunogenicity. The second patent introduces a di-substituted maleic amide linker that conjugates a strongly cytotoxic active substance to a biomacromolecule. This innovative linker significantly improves the substance homogeneity of the conjugate, enhancing its inhibitory activity on cell strains expressing the corresponding antigen.

Career Highlights

Zhiyan Du has worked with notable companies in the biotechnology sector, including Mabwell Bioscience Co., Ltd. and Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. His experience in these organizations has allowed him to contribute to the advancement of therapeutic solutions in the medical field.

Collaborations

Zhiyan Du has collaborated with esteemed colleagues, including Jingkang Shen and Tao Meng. These partnerships have fostered a collaborative environment that promotes innovation and the development of effective treatments.

Conclusion

Zhiyan Du's contributions to the field of biotechnology, particularly in antibody-drug conjugates, highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing cancer treatment methodologies.